In the subgroup analyses of regions (Table 3), we found that IL‐8 levels in the circulating blood of glioma patients were significantly increased in European populations, with a pooled SMD of 0.41 (95% CI: 0.08‐0.74; P = .014). Here, CXCL8 is linked to central nervous system cancer.